Yuma Clinical Trials
- Company typePrivate
- Founded2021
- HeadquartersYuma, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
Yuma Clinical Trials firmographics
Firmographics- Name
- Yuma Clinical Trials
- Legal name
- Yuma Clinical Trials, LLC
- Website
- https://yumaclinicaltrials.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Yuma Clinical Trials industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
Keywords
Where Yuma Clinical Trials is headquartered
LocationHeadquarters
- HQ city
- Yuma
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Yuma Clinical Trials business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: YCT conducts Phase 1-4 clinical trials for pharmaceutical sponsors and CROs. Revenue is generated through study contracts based on per-patient fees, monitoring visit fees, and site startup fees. The company serves pharmaceutical companies seeking to run clinical trials in an underserved desert community with access to a research-naive, majority-Hispanic patient population.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Clinical trial participation compensation varies by study |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Yuma Clinical Trials product offering
Product offeringCore offering
Yuma Clinical Trials is an independent, multi-specialty clinical research site conducting Phase 1-4 inpatient and outpatient studies across five clinic locations in Yuma, Arizona. The company operates a hybrid practice/research model combining independent private practices (cardiology, pulmonology, dermatology, internal medicine, CNS) with dedicated research staff, providing pharmaceutical sponsors and CROs with bilingual English/Spanish study execution, fully digital CRIO-based operations, and access to a research-naive, majority-Hispanic patient population of 200,000+ residents.
Product overview
Yuma Clinical Trials is an independent, multi-specialty clinical research site conducting Phase 1-4 inpatient and outpatient studies. The company operates as a single unified service offering (hybrid practice/research model) across five clinic locations in Yuma, Arizona, combining independent private practices with dedicated research staff. The core Clinical Research Services product encompasses patient recruitment, site operations, and data management. Supporting sub-brands include Pulmonology & Sleep Research (COPD, asthma, sleep apnea studies), Cardiology Research (cardiovascular trials), CNS Research (psychiatry studies), and Dermatology Research Ventures (plaque psoriasis, atopic dermatitis studies). Site operations are fully digital through CRIO platform with bilingual English/Spanish capabilities serving a majority-Hispanic patient population.
Differentiator
Problem solved
Functional benefit
Brands
- Yuma Pulmonary & Sleep Research: Pulmonary and sleep disorders research division led by Dr. Ashvin Shah, conducting COPD and asthma Phase III trials with on-site spirometry and overnight sleep studies.
- Yuma CNS Research
- Dermatology Research Ventures
Products and services
- Clinical Research Services Multi-therapeutic Phase 1-4 clinical trial site services combining independent private practices with dedicated research staff. Conducts inpatient and outpatient studies across five clinic locations in Yuma, Arizona, in therapeutic areas including hypertension, type 2 diabetes, dermatology (plaque psoriasis, atopic dermatitis), cardiology (heart failure, atrial fibrillation), psychiatry (MDD, bipolar disorder), obesity, osteoarthritis, and COPD/Asthma. Designed for pharmaceutical sponsors and CROs seeking diverse patient enrollment in an underserved community.
- Patient Recruitment and Retention Services Bilingual English/Spanish recruitment and retention services leveraging the CRIO recruitment database (780+ pre-screened candidates), physicians' private-practice records, and IRB-approved community outreach materials. Covers patient identification, pre-screening, outreach, scheduling, and retention across cardiometabolic, respiratory, CNS, dermatology, and musculoskeletal indications. Built for sponsors and CROs seeking diverse, research-naive enrollment.
- Site Metrics and Data Management Digital site operations platform powered by CRIO CTMS, eSource, and eRegulatory systems, providing electronic health records with certified copies for monitoring and audit, GDPR-compliant e-storage, and a quarterly-refreshed metrics dashboard for sponsors and CROs. Supports decentralized visit components and eConsent per protocol. Designed for sponsor/CRO monitoring and oversight requirements.
Quantifiable outcome
- 16 active portfolio studies with 5 currently enrolling and 2 in start-up
- +3 more outcomes
Companies that use Yuma Clinical Trials
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Yuma Clinical Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability1 record
Feature4 records
Yuma Clinical Trials partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Latinos In Clinical Research (LICR)coreYCT is an affiliate of Latinos In Clinical Research (LICR), and several of YCT's founders are also LICR founders. This partnership is central to YCT's mission of reducing patient disparities and improving representative enrollment in clinical research for the Hispanic/Latino community in Yuma County.
- CRIOcoreCRIO is the CTMS/eSource/eReg platform deployed site-wide for clinical trial management. YCT sources all site metrics directly from CRIO, including screening encounters, completed study visits, and recruitment database information.
- Advarra CIRBIcoreCentral IRB workflow managed through Advarra CIRBI. YCT's central IRB is Advarra (CIRBI).
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Yuma Clinical Trials competitors and assessment
Company assessmentDirect peers
- Centex Studies: Multi-therapeutic independent clinical research site organization conducting Phase II-IV trials for pharmaceutical sponsors; comparable as a privately-held, geographically concentrated SMO with similar therapeutic-area breadth.
- Velocity Clinical Research: Largest independent multi-therapeutic clinical research site network in the US, running Phase 1-4 trials across numerous therapeutic areas for top pharma sponsors; directly comparable as a site management organization serving similar sponsors with similar trial execution model.
- Circuit Clinical: Integrated clinical research site network that recruits from physician practices to run trials for pharma sponsors; highly comparable to YCT's hybrid private-practice/research model and sponsor-facing site services.
- Accel Research Sites: Multi-specialty clinical research site network conducting Phase I-IV trials for pharmaceutical sponsors across multiple therapeutic areas; closely comparable business model to YCT as an independent, site-based research provider.
- Elligo Health Research: Clinical research site network using a decentralized approach to connect patients and investigators to trials; comparable to YCT in serving pharma sponsors with site-based execution while also supporting decentralized trial components.
- DM Clinical Research: Independent multi-therapeutic clinical research site organization running Phase I-IV trials for pharmaceutical and CRO clients; comparable as a privately-held site management organization with similar sponsor relationships and therapeutic breadth.
- Javara Research Center: Integrated clinical research site network embedded within healthcare practices, conducting trials for pharma sponsors; comparable to YCT's hybrid private-practice/research model and multi-therapeutic trial delivery.
Broad incumbents
- IQVIA: Global CRO and clinical research services provider with site management capabilities and access to large patient populations; relevant as a broad incumbent that competes for sponsor site-management contracts YCT targets.
Market position
Strengths5 records
Weaknesses6 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Yuma Clinical Trials social profiles
Digital presenceYuma Clinical Trials compliance and trust
Trust signalCompliance1 record
Yuma Clinical Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yuma Clinical Trials leadership team
Management profileNumber of profiles
Profiles6 records
Yuma Clinical Trials subsidiaries and ownership
Company hierarchySubsidiaries3 records
Yuma Clinical Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yuma Clinical Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yuma Clinical Trials
What does Yuma Clinical Trials do?
Yuma Clinical Trials is an independent, multi-specialty clinical research site conducting Phase 1-4 inpatient and outpatient studies across five clinic locations in Yuma, Arizona. The company operates a hybrid practice/research model combining independent private practices (cardiology, pulmonology, dermatology, internal medicine, CNS) with dedicated research staff, providing pharmaceutical sponsors and CROs with bilingual English/Spanish study execution, fully digital CRIO-based operations, and access to a research-naive, majority-Hispanic patient population of 200,000+ residents.
Is Yuma Clinical Trials a public or private company?
Yuma Clinical Trials is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Yuma Clinical Trials founded?
Yuma Clinical Trials was founded in 2021. It employs 1 to 10 people.
Where is Yuma Clinical Trials based?
Yuma Clinical Trials is headquartered in Yuma, United States, in the North America region.
How does Yuma Clinical Trials make money?
One revenue line is on record: clinical Research Services.
Who are Yuma Clinical Trials's main competitors?
Direct peers on record are Centex Studies, Velocity Clinical Research, Circuit Clinical, Accel Research Sites, Elligo Health Research, DM Clinical Research and Javara Research Center. IQVIA is listed as a broad incumbent.
Does Yuma Clinical Trials have an API?
No public API is recorded for Yuma Clinical Trials.
What industry is Yuma Clinical Trials in?
Yuma Clinical Trials's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8000.